Security key
359616109
Fulcrum Therapeutics, Inc. - Common stock, par value $0.001 per share (FULC)
CUSIP: 359616109
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common stock, par value $0.001 per share
- Shares outstanding
- 66,594,760
- Total 13F shares
- 64,752,304
- Share change
- +4,435,478
- Total reported value
- $401,470,762
- Put/Call ratio
- 7.2%
- Price per share
- $6.20
- Number of holders
- 120
- Value change
- +$19,716,085
- Number of buys
- 77
- Number of sells
- 59
Report period
Q2 2024
Institutions
120
Top holders
10
FULC full security history
Newer quarter: Q3 2024
Previous quarter: Q1 2024
Fulcrum Therapeutics, Inc. SEC filings
Fulcrum Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 359616109
Recent filing periods:
Top shareholders of FULC - Fulcrum Therapeutics, Inc. - Common stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
17%
|
11,609,704
|
$109,595,606 | — | 31 Mar 2024 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
8.8%
|
5,845,956
|
$55,185,825 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
8.1%
|
5,364,665
|
$50,642,437 | — | 31 Mar 2024 | |
| COWEN AND COMPANY, LLC |
13F
|
Company |
5.6%
|
3,713,934
|
$35,059,536 | — | 31 Mar 2024 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
4.3%
|
2,848,486
|
$26,889,708 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.8%
|
2,538,665
|
$23,964,998 | — | 31 Mar 2024 | |
| TRV GP IV, LLC |
13F
|
Company |
3.5%
|
2,343,154
|
$22,119,374 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.3%
|
1,541,209
|
$14,549,013 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2%
|
1,325,379
|
$12,511,578 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
2%
|
1,304,812
|
$12,317,425 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1.7%
|
1,157,137
|
$10,923,373 | — | 31 Mar 2024 | |
| Jefferies Financial Group Inc. |
13F
|
Company |
1.7%
|
1,151,726
|
$10,872,293 | — | 31 Mar 2024 | |
| MPM BioImpact LLC |
13F
|
Company |
1.7%
|
1,137,108
|
$10,734,300 | — | 31 Mar 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.7%
|
1,106,422
|
$10,444,624 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.3%
|
897,461
|
$8,472,032 | — | 31 Mar 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
1.2%
|
823,098
|
$7,770,045 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.2%
|
810,270
|
$7,648,949 | — | 31 Mar 2024 | |
| Propel Bio Management, LLC |
13F
|
Company |
1.1%
|
750,000
|
$7,080,000 | — | 31 Mar 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
1.1%
|
727,673
|
$6,869,233 | — | 31 Mar 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
1.1%
|
723,163
|
$6,826,659 | — | 31 Mar 2024 | |
| Vestal Point Capital, LP |
13F
|
Company |
1%
|
695,000
|
$6,560,800 | — | 31 Mar 2024 | |
| Simplify Asset Management Inc. |
13F
|
Company |
1%
|
676,031
|
$6,381,733 | — | 31 Mar 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.94%
|
625,176
|
$5,901,662 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.85%
|
563,458
|
$5,320,502 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.84%
|
560,992
|
$5,295,764 | — | 31 Mar 2024 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.83%
|
550,339
|
$5,195,200 | — | 31 Mar 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.8%
|
535,062
|
$5,050,986 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.75%
|
496,679
|
$4,688,650 | — | 31 Mar 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.63%
|
420,200
|
$3,966,688 | — | 31 Mar 2024 | |
| STEMPOINT CAPITAL LP |
13F
|
Company |
0.61%
|
407,108
|
$3,843,100 | — | 31 Mar 2024 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.6%
|
398,436
|
$3,761,236 | — | 31 Mar 2024 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.51%
|
339,825
|
$3,207,948 | — | 31 Mar 2024 | |
| Caption Management, LLC |
13F
|
Company |
0.47%
|
315,460
|
$2,977,942 | — | 31 Mar 2024 | |
| BESSEMER GROUP INC |
13F
|
Company |
0.43%
|
286,988
|
$2,709,000 | — | 31 Mar 2024 | |
| Aberdeen Group plc |
13F
|
Company |
0.39%
|
256,888
|
$2,425,023 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.39%
|
256,861
|
$2,424,768 | — | 31 Mar 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.34%
|
225,573
|
$2,129,408 | — | 31 Mar 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.34%
|
223,400
|
$2,108,896 | — | 31 Mar 2024 | |
| Mass General Brigham, Inc |
13F
|
Company |
0.31%
|
205,356
|
$1,938,560 | — | 31 Mar 2024 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.3%
|
202,148
|
$1,908,277 | — | 31 Mar 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.28%
|
186,965
|
$1,764,950 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.27%
|
178,564
|
$1,685,644 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.26%
|
175,224
|
$1,654,115 | — | 31 Mar 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.26%
|
172,660
|
$1,629,910 | — | 31 Mar 2024 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.26%
|
171,507
|
$1,619,026 | — | 31 Mar 2024 | |
| Susquehanna Portfolio Strategies, LLC |
13F
|
Company |
0.25%
|
168,775
|
$1,593,236 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.24%
|
158,935
|
$1,500,347 | — | 31 Mar 2024 | |
| CIBC WORLD MARKETS CORP |
13F
|
Company |
0.23%
|
150,000
|
$1,416,000 | — | 31 Mar 2024 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.22%
|
149,627
|
$1,412,479 | — | 31 Mar 2024 | |
| Laurion Capital Management LP |
13F
|
Company |
0.22%
|
144,721
|
$1,366,166 | — | 31 Mar 2024 |
Institutional Holders of Fulcrum Therapeutics, Inc. - Common stock, par value $0.001 per share (FULC) as of Q2 2024
As of 30 Jun 2024,
Fulcrum Therapeutics, Inc. - Common stock, par value $0.001 per share (FULC) was held by
120 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
64,752,304 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., RTW INVESTMENTS, LP, FMR LLC, BlackRock Inc., VANGUARD GROUP INC, COWEN AND COMPANY, LLC, SUVRETTA CAPITAL MANAGEMENT, LLC, TRV GP IV, LLC, CITADEL ADVISORS LLC, and DIMENSIONAL FUND ADVISORS LP.
This page lists
120
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
122
Q2 2024 holders
120
Holder diff
-2
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.